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Abstract: Covarying phenotypic traits can limit natural selection’s ability to modify these traits. Most evolutionary stud-
ies on trait covariation use the comparative method to study complex traits of multicellular organisms. Simpler traits have 
the advantage of being amenable to experimental evolution. Here we study such a simple molecular system, the TEM-1 
beta-lactamase protein, a promiscuous enzyme that hydrolyses antibiotics, and thus confers antibiotic resistance to bacte-
ria. We mutagenized large populations of TEM-1, and selected in these populations for activity on the four different anti-
biotics ampicillin, carbenicillin, oxacillin, and penicillin G. While mutagenesis alone lead to highly correlated changes in 
enzyme activity on the four antibiotics, subsequent selection was able to modify this activity covariation substantially, and 
even lead to uncorrelated activities. We found that selection on one antibiotic A may be more effective in increasing activ-
ity on another antibiotic B then selection on antibiotic B itself. We call this phenomenon phenotypic hitchhiking. It can be 
readily explained through quantitative genetic theory as a consequence of differing variances in covarying traits. It may 
help engineer macromolecules with desirable properties through directed evolution. Our analysis is a first step towards 
systematic analysis of trait covariation in experimental molecular systems. It shows that selection may readily modify the 
phenotypic constraints that limit its efficacy.  
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INTRODUCTION 
 An organism or genotype shows phenotypic plasticity if 
it can form more than one phenotype depending on its envi-
ronment. Phenotypic plasticity is ubiquitous, and occurs on 
all levels of biological organization, from visible, macro-
scopic phenotypes down to the conformations of molecules 
[1-17]. Historically, most studies of plasticity have focused 
on macroscopic or physiological traits [1]. However, in re-
cent years, evidence for the plastic traits of individual mole-
cules has been mounting. Such plasticity is usually called by 
different names, such as cross-reactivity, substrate ambigui-
ty, moonlighting, or promiscuity [15-19]. The phenotype in 
question is a spatial fold (conformation) of a molecule that 
changes in time and permits the molecule to interact with 
different other molecules. Promiscuity, for example, is a 
property of many enzymes whose catalytic abilities are not 
highly specific to one substrate molecule. Instead, such en-
zymes can catalyze reactions with different substrate mole-
cules [15, 16, 18]. Promiscuity is an instance of phenotypic 
plasticity, if one considers that any one enzyme molecule 
exists in continually fluctuating molecular environments, for 
example through the thermal motions of molecules in its  
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vicinity. In consequence, its conformation changes incessant-
ly, thus also altering its ability to react with any one substrate 
molecule.  
 How phenotypes (plastic or not) change in response to 
natural selection is among the most central questions of evo-
lutionary biology. Complex phenotypes are not univariate – 
variable along one scalar axis – but multivariate. Examples 
include the shapes of vertebrate skulls and jaws, whose de-
scription involves dozens of morphometric landmarks, 
cuticular hydrocarbon composition of plants, or an individu-
al’s fitness itself, which can be decomposed into multiple 
scalar life history traits, such as survivorship or fecundity 
[20-22]. The individual scalar traits that compose such com-
plex phenotypes typically do not vary independently, but 
show covariation within a population. If natural selection 
changes one trait, correlated changes in others often occur. 
The causes and consequences of such correlated changes – 
often referred to as phenotypic constraints – are the subject 
of an enormous body of literature [21, 23-36].  
 One can distinguish two fundamental kinds of correlated 
changes in quantitative traits. In the first, an increase in some 
trait X on which natural selection acts directly causes a cor-
related increase in some other trait Y. In other words, the two 
traits covary positively. In the second kind of correlated 
change, an increase in trait X causes a decrease in trait Y. In 
this case, the two traits X and Y covary negatively, which 
may reflect a trade-off between the traits. Trade-offs are fre-
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quent from molecular to organismal phenotypes, and espe-
cially in life-history traits [22, 37-42].  
 In both kinds of correlated change, phenotypic evolution 
is constrained by trait covariance. That is, natural selection 
can change several covarying traits in some directions but 
not in others, at least on short evolutionary timescales. On 
longer evolutionary timescales, this covariance itself can 
change, such that traits that show strong positive covariance 
in one species, may covary less, not at all, or even negatively 
in another species [20, 21, 27-29, 43-47]. For multiple 
univariate phenotypic traits P1, …, Pn trait covariance is usu-
ally described by a phenotypic covariance matrix P whose 
entries describe the covariance between traits Pi and Pj. 
Closely related to this matrix is the genetic covariance matrix 
G, which describes phenotypic covariation that is due to 
genotypic differences among organisms. The structure of G 
is much more difficult to estimate, which is why most perti-
nent studies focus on phenotypic covariation [27]. 
 Trait covariation is well studied for macroscopic pheno-
types, but much less so for molecular phenotypes. Here we 
analyze trait covariances and correlations for the promiscu-
ous activity of an enzyme, where trait Pi corresponds to the 
enzyme’s catalytic activity on some substrate i. While pro-
miscuous activities have been studied in many enzymes [15-
18, 48, 49], there is very little systematic work on how dif-
ferent promiscuous activities covary. However, such covari-
ance could be quite important to understand the evolution of 
protein functions and its limits, a topic of interest not only to 
evolutionary biologists but also to protein engineers [17, 18]. 
Positive covariance of a protein’s activity on different sub-
strates means that one cannot increase activity on one sub-
strate, without also increasing activity on another substrate. 
If the second substrate is an undesirable byproduct of a reac-
tion, this covariation would need to be reduced before engi-
neering a protein with high specificity to the first substrate. 
Conversely, enzymes may face trade-offs between activity 
on different substrates, where an enzyme highly active on 
one substrate would have little activity on other substrates 
Candidate examples are reviewed in [18]. In such enzymes, 
simultaneous high activity on multiple substrates might be 
difficult to engineer or evolve. Although one might think that 
such trade-offs must be very frequent, some studies fail to 
show them [18, 49]. A case in point is a recent laboratory 
evolution study on paraoxonase, bacterial phosphotriesterase, 
and carbonic anhydrase, three different promiscuous en-
zymes. This study identified mutations that increased the 
enzymes’ activity on a minor, promiscuous substrate, while 
affecting activity on the major substrate little, or even in-
creasing this activity [49]. Studies like this typically compare 
only few (as few as two) variants of a protein [18], which is 
insufficient to ascertain a trade-off or any other pattern of 
covariation with much confidence. For that purpose, one 
needs to study trait covariation more systematically and for 
larger samples.  
 We here provide a first step towards marrying well-
established methods in evolutionary genetics with laboratory 
evolution of protein molecules. We do so for a paradigmatic 
example of a promiscuous enzyme, the β-lactamase TEM-1. 
β-lactamases are enzymes that hydrolyze antibiotics with a 
four carbon ring structure called a β-lactam. This class of 
antibiotics includes prominent molecules, such as penicillin 
and ampicillin [50, 51]. β-lactam antibiotics interfere with 
proteins required for synthesizing the bacterial cell wall. 
Through their ability to inactivate these antibiotics, β-
lactamases are a major cause of bacterial resistance against 
antibiotics. We randomly mutagenized DNA molecules en-
coding TEM-1, and subjected four separate populations of E. 
coli cells expressing these molecules to selection for re-
sistance against the four antibiotics ampicillin (A), 
carbenicillin (C ), oxacillin (O), and penicillin G (P). From 
each of the resulting four populations, we isolated 48 clones. 
We then measured the hydrolytic activity of each TEM-1 
clone on all four antibiotics, and studied the change in this 
activity individually, as well as for all pairs of antibiotics, 
through their phenotypic covariance matrix P. We find that 
selection can change the pattern of activity covariation rapid-
ly, and allows for a phenomenon that we call phenotypic 
hitchhiking, which can be explained through basic quantita-
tive genetic theory.  
MATERIALS AND METHODS 
Vector Construction and Host Strain Transformation 
 The starting point of our work is the class A serine β-
lactamase TEM-1, a well studied enzyme [50-52]. Its coding 
DNA sequence can be found in the European Nucleotide 
Archive (Database ID AP010961.1 at http://www.ebi.ac.uk/ 
ena/) . We had a DNA fragment containing the TEM-1 cod-
ing sequence synthesized by GENEART (Regensburg, Ger-
many). The fragment comprises position 114462 to 113652 
of the above database entry. 
 Our cloning vector is a derivative of the low copy num-
ber plasmid pUA66 [53], which we obtained by placing a 
cassette comprising the lac-promoter and a multiple cloning 
site from plasmid pSK (Stratagene, La Jolla CA, USA) up-
stream of the EGFP gene in pUA66. We obtained this cas-
sette through polymerase chain reaction (PCR) amplification 
of pSK, using the primer LacBX (39bp: 5’ CGGAA GATCT 
CGAGC GTTTA CACTT TATGC TTCCG GCTC 3’) up-
stream of the lac promoter with respect to the multiple clon-
ing site, and the bacteriophage T7-primer (20bp: 5’ TAATA 
CGACT CACTA TAGGG 3’) heading in the opposite direc-
tion, and cloned the amplified fragment into the BglII and 
Xho sites of plasmid PUA66. The important features of this 
plasmid are a gene encoding resistance to the antibiotic kan-
amycin, which we used to select for the presence of the vec-
tor in transformed cells, as well as a lac promoter, which 
drives the expression of a DNA insert. We used E.coli strain 
Dh5α as a cloning host, which confers expression of the lac 
promoter even in the absence of an inducer [54]. We ex-
pressed the inserted gene without adding inducer during our 
selection experiments, in order to enable selection using low 
antibiotic concentrations and, more importantly, to alleviate 
previously demonstrated selection against high level-
expression of our focal proteins [54]. 
 To clone the TEM-1 DNA into the cloning vector, we 
first digested the vector with the restriction enzymes SmaI 
and EcoRI, which creates one blunt end and one overhanging 
end. We then PCR-amplified the TEM-1 DNA using the 
primers P1 and P2 (P1: 5’GG AGC TTA TGA GTA TTC 
AAC ATT TTC GTG 3’, P2: 5’ AA TTG GAT CCT CAT 
CCA TAG TTG CCT GAC3’), which introduce restriction 
sites for the enzyme EcoRI at their end. We then took ad-
vantage of the 3’-5’ exonuclase activity of the Klenow frag-
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ment of DNA polymerase to render one of the amplified 
DNA’s ends blunt-ended, while leaving the other end com-
plementary to an EcoRI restriction site on the 3’ end. We 
used this procedure because preliminary experiments (not 
shown) had demonstrated that this procedure was more than 
50 times more efficient than blunt end cloning. Specifically, 
we added the Klenow fragment to the PCR-amplified insert 
in a 20 µl reaction volume using 0.2 U/ml Klenow enzyme in 
NEB Buffer 2 (both NEB, New England Biolabs, Ipswich 
MA, USA) supplemented with dCTP at 50 uM. The reaction 
proceeded at 37°C for 30 minutes. We ligated the products 
of this reaction into the cloning vector in a 20 µl reaction 
volume, using a cyclic temperature change regime (10 
minutes at 30°C followed by 10 minutes at 10°C, repeated 
48 times), after which we heat-inactivated the ligation reac-
tion 60°C for 20 min.  
 We used the following procedure (modified from [55, 
56]) to prepare chemically transformation-competent E. coli 
cells of strain Dh5α . Briefly, after growth at 20°C to an op-
tical density (OD) 600 of 0.3, using SOB medium( 0.5% w/v 
yeast extract, 2% w/v tryptone, 10 mM NaCl, 2.5 mM KCl, 
and 20 mM MgSO4), we collected cells by centrifugation 
(3000xg, 10 minutes, 4°C). After resuspension in 40% of the 
original culture volume in buffer CCMB80 (10 mM KOAc 
pH 7.0, 80 mM MnCl2, 10mM MgCl2, 10% v/v glycerol, 
pH adjusted to 6.4 if required using 0.1N HCl, sterile filtrat-
ed and kept at 4°C), cells were kept on ice for 20 minutes. 
Following another collection using centrifugation under the 
same conditions, we resuspended cells again in CCMB80 
buffer, but now in 4 percent of the initial culture volume.  
 After another incubation on ice for 20 min, we used cells 
for transformation either immediately or aliquoted them and 
stored them at -80°C for later use. We used 100ul of compe-
tent cells for transformation under the following protocol. 
We briefly thawed aliquots of chemically competent cells on 
ice, and added 10 µl of a ligation reaction. We incubated the 
cell suspension for 30 minutes on ice, heat-shocked it for 60 
minutes in a water-bath at 42°C, and added 900 µl SOB sup-
plemented with glucose to 20 mM. After recovery of the 
cells for 90 minutes under vigorous agitation at 37°C, which 
enables expression of the kanamycin resistance gene of the 
plasmid, we plated 50ul of transformed cells on LB plates 
containing kanamycin at 30 µg/ml to select for successful 
transformation. We continued further experimentation with 
transformed cells only if at least 1000 clones were obtained 
on this reference plate.  
PCR Mutagenesis 
 For PCR-based mutagenesis, we used the same primer 
pair P1 and P2 described above, and the Taq-Polymerase 
(2.5 U/ reaction),(NEB)) under the following reaction condi-
tions:20 ng template, 0.2 mM dGTP, 0.2mM dATP, 1.0 mM 
dCTP, 1.0 mM dTTP with standard Taq-buffer, supplement-
ed with 1.5 mM MgCl2, 1.5 mM MnCl2, and 2.5 U Taq in a 
100 µl reaction volume. The cycling protocol comprised 25 
cycles (each 94°C for 1 min, 45°C for 1 min and 72°C for 1 
min). Based on previous observations [57] this procedure 
introduces an expected number of approximately 0.0066 
nucleotide changes per nucleotide and PCR reaction, which 
yields an expected number of 0.0066x810≈5.3 mutations for 
the 810 base pair long amplified TEM-1 coding sequence. 
This mutagenic PCR protocol has only a mild bias towards 
mutations away from T and towards A [57]. We cloned the 
reaction products into the cloning vector using the protocol 
we described above under vector construction. We estimate 
that the mutagenized population comprises 1.5x1010 TEM-1 
molecules, an assertion that is based on the 20 ng purified 
DNA used for the ligation reaction, a fragment length of 827 
bp, as well as the fact that 1kb of DNA comprises approxi-
mately 9.1x1011molecules per µg. Under our reaction condi-
tions, and under the assumption that mutations follow a Pois-
son distribution, we expect only a tiny fraction of exp(-
5.3)≈0.005 of sequences to have experienced no mutation. 
Cultivation Conditions and Selection 
 Immediately after transformation of cells with ligation 
products as described above, we plated a small aliquot on 
solid LB-medium (Becton Dickinson, 1.5% agarose) con-
taining kanamycin alone to estimate the absolute number of 
clones entering selection for each of the four focal antibiot-
ics. We distributed the remaining volume on plates with the 
same medium supplemented with individual antibiotics at 
two different concentrations, as specified below, and incu-
bated the plates over night at 37°C. In order to standardize 
the cultivation conditions, we prepared all plates fresh on the 
day of the experiment. We added the agar to solid antibiotics 
and used a total agar volume of 15 ml for each 100mm petri 
dish. After overnight cultivation, a plate needed to show suf-
ficiently many colonies for isolation of multiple clones (see 
below), yet not too many to prevent picking of individual 
colonies. To achieve the best colony density, we explored 
two different antibiotic concentrations, as we describe now. 
For selection on ampicillin, we plated approximately 2.7×104 
cells on two plates containing 200 and 300 µg/ml of ampicil-
lin, and picked colonies for further analysis from the latter 
plate. For selection on carbenicillin, we plated approximately 
2.5×104 cells on two plates containing 250 and 375 µg/ml of 
carbenicillin, and picked colonies for further analysis from 
the latter plate. For selection on oxacillin, we plated approx-
imately 2.3×104 cells on two plates containing 250 and 375 
µg/ml of oxacillin, and picked colonies for further analysis 
from the latter plate. For selection on penicillin G, we plated 
approximately 2.1×104 cells on two plates containing 200 
and 300 µg/ml of penicillin G, and picked colonies for fur-
ther analysis from the latter plate. Under these conditions, we 
usually observed 200-500 colonies per plate. We picked mul-
tiple clones from each plate (see below), and washed the 
remaining colonies off the plate using LB medium to create 
glycerol stocks. 
 We also explored the effects of mutagenesis in the ab-
sence of selection. To this end, we plated 50 µl of a trans-
formation mixture on a plate containing only kanamycin at 
30 µg/ml , and incubated the plate over night at 37°C.  
Clone Isolation 
 From each of the five plates thus described, we picked 54 
colonies, and streaked them on LB-plates containing kana-
mycin at 30 µg/ml (and no further antibiotics). We chose this 
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number of clones to enable the preparation of about 48 cell 
extracts for activity measurements, the excess accounting for 
the possibility that some picked clones may fail to form col-
onies after transfer from the primary plate. Each clone was 
assigned an individual number. 
Periplasmic Extracts 
 From each clone, we inoculated a pre-culture in one well 
of a 96-well plate, with a culture-volume of 150µl using LB-
medium with kanamycin at 30 µg/ml. This inoculum was 
allowed to grow for 6 to 8 hours at 37°C on an incubator-
shaker at 650 rpm ( VWR, model 980141CH). We then used 
20µl of this preculture to inoculate a 96 deep-well plate 
(Sarstedt, 82.1972.002) with a culture volume of 1.5 ml con-
taining one glass bead (4 mm, Merck) per well, using the 
same medium as for the pre-culture, but supplemented with 
200 µM IPTG, to increase beta-lactamase expression, and 
thus allow for activity measurement of enzymes with low 
specific activities.  
 After growth overnight (37°C, 650 rpm) we prepared 
periplasmic extracts using a modification of a protocol de-
scribed by [58]. Briefly, we collected cells by centrifugation 
for 20 minutes at 2250xg at 4°C. We removed the superna-
tant and resuspended the pellets in 100 µl chilled extraction 
buffer (0.2M Na-Acetate, pH 5.9, on ice). The glass beads 
we had used during growth in the deep-well plates facilitated 
resuspending the cell pellets with a vortex mixer. We then 
conserved the cells prior to extraction by transferring them to 
96-well Multiply PCR-plates (Sarstedt, Nümbrecht, Germa-
ny, 72.1978.202) sealed with sealing-tape (Sarstedt, 
95.1994), and by freezing these plates at -20°C for further 
processing. We next describe how to prepare the 
periplasmatic fraction. We briefly thawed plates containing 
the cell suspensions at ambient temperature, and followed 
this treatment by four-freeze thaw cycles. Each of these cy-
cles proceeded as follows: brief immersion of the plate into 
liquid nitrogen until the sizzling sound of boiling nitrogen 
ceases, incubation of plates in a water bath (10 minutes at 
37°C) homogenization of content of the wells by vortexing. 
After these cycles we added another 100 µl extraction buffer 
to the wells, and kept the extracts on ice for 30 minutes. Sub-
sequently, we clarified the extracts by centrifugation (30 
minutes, 13000xg, 4°C). We transferred the supernatant for 
each culture to 1.5 ml Sarstedt screw-cap-tubes (Sarstedt, 
72.692) and stored it at -20°C for enzymatic analysis.  
Enzyme Activity Measurements 
 We used microiodometry to determine the hydrolytic 
activity of different TEM-1 variants on the four antibiotics 
we studied. In this method, a starch iodine complex is decol-
orized by penicilloic acid, which is formed by the action of 
β-lactamase on penicillins [59]. For the starch solution, we 
prepared hydrolyzed starch using a suspension of 5% soluble 
starch, which we boiled to form a viscous solution. To this 
solution we added concentrated hydrochloric acid to a final 
concentration of 10 mM, and continued boiling for 10 
minutes. To quench starch hydrolysis, we chilled the reaction 
while stirring it on ice, and neutralized it using sodium car-
bonate. To prepare the iodine-starch reagent used in the as-
say, we supplemented 50 mM potassium phosphate (pH 5.9) 
with starch solution to a 0.5% final concentration, and to 270 
µM in iodine using an iodine stock solution (80mM I2 / 
3.2M KI). For activity measurements, we supplemented 50 
mM potassium phosphate with the iodine-starch reagent to a 
final starch concentration of 0.16 % and with the individual 
β-lactam antibiotic to 400µM in each well. 
 In order to standardize the measurements, we thawed the 
Sarstedt-tubes containing periplasmic extracts (see above) 
briefly using an ice-bath, centrifuged them (15000xg, 20 
minutes, 4°C), and kept them on ice throughout the analysis. 
Furthermore, we let the mixtures containing the iodine/starch 
reagent and the individual substrates equilibrate for 20 
minutes at room temperature prior to transfer to 96-well 
plates (Sarstedt, 95.1994) for measurement, as we describe 
next.  
 To each well of a 96-well plate we added 175 µl reagent, 
which we supplemented with 10µl diluted periplasmic ex-
tract with the aid of a 8-channel multipipettor (BioHit, Hel-
sinki, Finland). Specifically, we diluted the extract 1:1 for 
measurement of activity on carbenicillin and oxacillin, and 
1:9 for measurement of activity on penicillin G and ampicil-
lin as substrates, using 50mM potassium phosphate (pH 5.9) 
supplemented with a trace of BSA.  
 We followed the absorption of the reaction mix at 600 
nm using a microplate-reader (Infinite F200 Pro, TECAN, 
Männedorf, Switzerland), which was temperature controlled 
at 30°C, and was equipped with a 600nm filter. We set the 
time interval between successive reads from a single well to 
80s, and used linear regression of the absorptions over time 
for individual wells to estimate the reaction-rates. In each 96 
well plate, we also used blank reactions comprising sample-
buffer and extraction-buffer in the same ratios as used for the 
measurements of the extracts, in order to estimate back-
ground reaction rates arising from the spontaneous decompo-
sition of substrates. We measured all extracts in duplicate (in 
different wells), and included only data in our analysis where 
the duplicate measurements deviated from each other by less 
than 15 percent.  
 To determine the activity of the ancestral TEM-1 clone 
on the four different antibiotics, we obtained single colonies, 
and prepared inocula, cultures, and extracts as described for 
the mutagenized/selected populations above. 
 The resulting measurements yield information about the 
activity of β-lactamases expressed per unit volume (mODU 
(min-1) (10 µl extract)-1), i.e., the volumetric activity, which 
meets our requirements, as we are mainly interested in rela-
tive activities among different clones, not in establishing 
absolute activity values.  
Statistical Analysis of Covariance Matrices 
 To compare correlation or covariance matrices is non-
trivial, because any two such matrices could differ in more 
than one way. Multiple methods to compare correlation or 
covariance matrices exist [21, 23, 25, 27, 60-63]. Among 
them, we chose common principal component analysis 
(CPCA), because it allows one to compare different aspects 
of matrix structure [60, 64]. It is built on principal compo-
nent analysis, a multivariate statistical technique that aims to 
identify directions in a set of multivariate data (a cloud of 
points in an n-dimensional space) along which most of the 
variation in the data occurs [65]. Principal component analy-
sis computes a new coordinate system in this space, where 
the largest amount of variation in the original quantity occurs 
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along the first axis (the first principal component), the se-
cond largest amount along the second principal component, 
and so on. These principal components are the eigenvectors 
of the covariance matrix of the data, sorted by descending 
magnitude of the eigenvalue associated with each eigenvec-
tor. Principal component analysis is usually used to reduce 
the complexity of high-dimensional data sets, but it can also 
serve as a starting point to compare the structure of two or 
more covariance matrices, that is, for CPCA. CPCA is based 
on the so-called Flury hierarchy of shared principal compo-
nents between covariance matrices [64]. It starts with the 
observation that two covariance matrices can be either exact-
ly equal, or they can differ in multiple different ways. First, 
and most trivially, the entries of two matrices may differ by a 
single multiplicative constant. Second, two matrices may 
have identical principal components but different eigenval-
ues. Third, they may differ in one of their principal compo-
nents. Fourth, they may differ in two, three, or more princi-
pal components, up to n-2 principal components. Because 
principal components are by definition orthogonal to one 
another, the first n-1 principal components completely de-
termine the remaining principal component. Thus, matrices 
that differ in all n-1 principal components are completely 
unrelated to one another. These different levels of matrix 
similarity are hierarchical, in the sense that matrices which 
share, say, three principal components, also automatically 
share two different principal components. CPCA tests the 
above null-hypotheses of matrix similarity for two or more 
covariance matrices. We used the software cpc 
[http://pages.uoregon.edu/pphil/software.html, 60] in all such 
hypothesis testing. We note that CPCA is designed for co-
variance and not correlation matrices. 
RESULTS 
Different Selection Regimes Show Different Average 
Trait Outcomes 
 We first created a population of approximately 1.5x1010 
TEM-1 variants using PCR mutagenesis (see Methods), and 
transformed E. coli cells with an expression vector that en-
coded these variants. For each of our focal antibiotics 
(P,A,C,O) we then plated between 20,000 and 30,000 
transformants on agar plates with solid LB medium that con-
tained the antibiotic for selection. From the surviving colo-
nies, we selected 48 clones, prepared periplasmic extracts 
from them, and measured the volumetric hydrolytic activity 
– referred to below simply as activity – of the β-lactamase 
they encode. Importantly, we measured the activity of each 
clone on all four different antibiotics. In addition, we also 
measured the activity of 48 mutagenized variants that had 
not been subject to selection on any of the four antibiotics 
(Fig. 1). All activity measurements we report use volumetric 
units of Optical Density change [mODU (min-1) (10 µl ex-
tract)-1]. 
 Two processes with opposing effect influence the hydro-
lytic activities of the β-lactamases in the population that sur-
vives selection. The first is mutation, which tends to reduce 
the average activity relative to the wild type ancestor. The 
second is selection, which tends to increase the average ac-
tivity, because it eliminates clones with low activity. When 
mutation and selection interact, three qualitatively different 
outcomes are possible. The first occurs if mutagenesis creat-
ed few or no molecules with higher activity than the ances-
tral molecule. Because mutation reduces activity on average 
[66-69], this means that the average activity of survivors will 
also be reduced. In the second outcome, the effects of both 
processes balance each other, such that no change in the av-
erage activity relative to the ancestor occurs. In the third 
outcome, mutagenesis creates many variants that confer 
higher activity than the ancestor, leading to an increased av-
erage activity of the survivors.  
 Our experiments show instances of the first scenario (for 
carbenicillin), the second scenario (oxacillin and penicillin 
G), and the third scenario (ampicillin, Fig. 2). Specifically, 
on carbenicillin, mutagenesis dramatically reduced activity 
to 13.8(±5.9 s.dev.) compared to 123.6±6.9 in the ancestor (a 
difference significant at p=0.001, Mann-Whitney U-test). 
Selection increased activity more than four-fold to 
64.3±21.2, but did not recover the ancestral activity fully 
(p=0.0017, Mann-Whitney U-test, Fig. 2A).The mean activi-
ty of the TEM-1 ancestor on oxacillin was equal to 43.9 ±7.3 
, whereas after mutagenesis, this activity reduced to 21.15 
±16.7, which is statistically significantly lower (p=0.02, 
Mann-Whitney U-test ). After the subsequent selection step, 
this activity recovered to a level statistically indistinguisha-
 
Fig. (1). The experimental design used in this study.  
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ble from that of the ancestor (39±12, p=0.36, Mann-Whitney 
U-test, Fig. 2B). On penicillin G, mutagenesis reduced activ-
ity significantly from 624.2±44.5 in the ancestor to 
227.9±202 in the mutagenized population (p=0.003, Mann-
Whitney U-test), and selection increased the activity to a 
level that is indistinguishable from the ancestor (606.8±335, 
p=0.19, Fig. 2C). Finally, on ampicillin, the ancestor showed 
an activity of 985.7±36.8, which mutagenesis reduced signif-
icantly by more than 50 percent to 431±360.1 (p=0.01, 
Mann-Whitney U-test). The subsequent selection step in-
creased mean activity significiantly (p=0.015, Mann-
Whitney U-test ) to approximately 40 percent above that of 
the ancestor (1390.4±478.1, Fig. 2D). In sum, mutagenesis 
significantly reduced activity on all four antibiotics, a reduc-
tion for which subsequent selection could partially or fully 
compensate (Fig. 2). 
Activities on Different Antibiotics Covary Positively 
 We next asked to what extent the activities on different 
antibiotics are positively correlated, negatively correlated, or 
uncorrelated. We first focused on 48 clones that had been 
subjected to mutagenesis only, without subsequent selection 
on any antibiotic. Fig. (3) shows the result in the form of 7 
pairwise scatterplots. All pairwise activities are highly posi-
tively correlated, with a Pearson correlation coefficient 
r>0.96 that is highly significantly different from zero  
(p<10-17). The matrix in Fig. (5A) summarizes these Pearson 
correlation coefficients below the diagonal in black type. 
(Diagonal and upper diagonal entries correspond to pheno-
typic variances and covariances of these traits.) This obser-
vation shows that mutation alone induces highly correlated 
changes in activities on different antibiotics. It suggests that 
the effects of most mutations are not specific to one antibi-
otic, but reduce activity on all antibiotics in a similar way.  
 We next asked the same question for all 48 clones isolat-
ed from each selection line. Fig. (4) shows, as an example, 
pairwise scatterplots of these activities for the population 
selected on ampicillin, where selection increased activity to 
the greatest extent. The data shows that some activities are 
highly correlated in this population, for example activity on 
ampicillin and on penicillin G (top left panel, r=0.89, p<10-3). 
Others are more weakly correlated, for example, activity on 
oxacillin and on penicillin G (bottom left panel, r=0.38, 
p<0.008). The matrix in Fig. (5B) shows below its diagonal 
the pairwise Pearson correlation coefficients for this popula-
tion. It indicates that four of the seven pairwise correlation 
are positive, whereas two (C-P, C-A) are not significantly 
different from zero. Note that not a single correlation is sig-
nificantly negative.  
 The lower-diagonal matrices Fig. (5C) through 5E sum-
marize the same data for the three populations that we sub-
jected to selection on carbenicillin, oxacillin, and penicillin 
G. The data show that the nature of the selection influences 
the extent to which individual activities are correlated. For 
example, after selection on oxacillin only two pairs of activi-
ties show a significantly positive association, whereas after 
selection on penicillin G (Fig. 5E), all pairs show not only a 
significant association, but this association exceeds r=0.86 
for every single pair.  
 In sum, mutagenesis alone introduces highly correlated 
changes in activity on individual antibiotics. These correla-
tions can be substantially weakened by selection. Their mag-
nitude depends on the kind of selection applied to a popula-
tion. Not a single pair of antibiotics exhibits the significantly 
negative association of activity that might be indicative of a 
trade-off.  
 Visual inspection of matrix entries in Fig. (5) can reveal 
differences in how activities on pairs of antibiotics covary, 
but it does not answer how similar or different the matrices 
 
Fig. (2). Activity changes of TEM-1 β-lactamases after mutagene-
sis and selection on four different antibiotics. The vertical axes 
show means (dots) and one standard error of the mean (bars) in 
activity of 48 clones of TEM-1 β-lactamase on the antibiotic indi-
cated in the inset. The horizontal axes indicate whether the clones 
stem from populations that had only been subject to mutagenesis 
(left) or to mutagenesis followed by selection (right) on A) 
carbenicillin, B), oxacillin, C) penicillin G, and D) ampicillin. Hor-
izontal lines indicate the mean activity of the TEM-1 ancestor on 
each antibiotic. Units are mODU (min-1) (10 µl extract)-1. 
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are as a whole. To answer this question, we applied common 
principal component analysis (CPCA, see Methods) to phe-
notypic covariances that we computed from our five popula-
tions (mutagenized-only, mutagenized and selected on A, C, 
P, and O). CPCA allows us to ask whether all principal com-
ponents of two or more covariance matrices are equal, 
whether these principal components are unequal but propor-
tional to one another, and whether the matrices share any 
number of principal components. The answer to all three 
questions was no (p<10-4). This means that the five covari-
ance matrices as a group are unrelated. We then carried out 
four additional CPCAs, each for a pair of matrices, where we 
paired the matrix from a selected population with that from 
the mutagenized population, and did so for the populations 
selected on A,C, P, and O. For each of these pairs, and for 
each of the hypotheses of shared matrix structure, CPCA 
rejected the hypothesis at p<10-4. This means that selection 
alters the covariation of activity on the four antibiotics, such 
that it becomes statistically unrelated to covariation after 
mutagenesis. Finally, we also compared covariance matrices 
for those selection lines that shared the greatest number of 
significant correlations (carbenicillin and penicillin, Fig. 5C 
and 5E). Again, CPCA rejected any of the possible hypothe-
ses of shared matrix structure. In sum, according to CPCA, 
the patterns of activity covariation that we observe appear 
statistically unrelated among mutagenized and selected lines.  
 
Fig. (3). Covariation of activity on four antibiotics after mutagenesis. All data in this figure are based on 48 clones from TEM-1 populations 
subject to mutagenesis but no subsequent selection (Fig. 1). The four histograms in the diagonal of the lower-diagonal matrix indicate, from 
top to bottom, the distribution of activities of these clones on penicillin G, ampicillin, carbenicillin, and oxacillin. The scatterplots indicate 
activities on pairs of antibiotics, as indicated to the left of each row and on the bottom of each column. Axes scales are omitted for clarity and 
correspond to the following intervals bounded by minimal and maximal measured activity values: (25.8, 839.0) on penicillin G, (48.9, 
1418.6) on ampicillin, (6.0, 27.0) on carbenicillin, (3.7, 58.2) on oxacillin. 
 
Fig. (4). Covariation of activity on four different antibiotics after selection for activity on ampicillin. All data in this figure are based on 48 
clones from TEM-1 populations subject to mutagenesis and subsequent selection for activity on the antibiotic ampicillin (Fig. 1). The four 
histograms in the diagonal of the lower-diagonal matrix indicate, from top to bottom, the distribution of activities of these clones on penicil-
lin G, ampicillin, carbenicillin, and oxacillin. The scatterplots indicate activities on pairs of antibiotics, as indicated to the left of each row 
and on the bottom of each column. NS: not significant. Axes scales are omitted for clarity and correspond to the following intervals bounded 
by minimal and maximal measured activity values: (182.3, 1339.2) on penicillin G, (280.0, 2325.8) on ampicillin, (52.0, 221.2) on 
carbenicillin, (18.1, 108.3) on oxacillin. 
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Most Phenotypic Variation we Observe Reflects Genetic 
Variation 
 Phenotypic variation in activity among TEM-1 clones has 
two principal sources. The first is genetic differences in the 
clones caused by mutagenesis. The second comprises the 
inevitable environmental differences that clones experience 
as they grow from single cells, and as these cells are pre-
pared for activity measurements. Cast in the language of 
quantitative genetics, the phenotypic variance VP in activity 
is composed of a genetic variance VG and an environmental 
variance VE. In the absence of genotype-by-environment 
interactions, VP=VG+VE [70]. From an evolutionary stand-
point, the genetic variance is especially important, because it 
is mostly genetic variation that is inherited from generation 
to generation, especially in a system as simple as our study 
protein.  
 All variation in activity measurements that we reported 
so far reflect phenotypic variation, and not necessarily genet-
ic variation. To find out which part of phenotypic variation 
reflects genetic variation one can carry out an analysis of 
variance [70, Chapter 18], which requires multiple replicate 
activity measurements of each clone. While such replication 
would be too time-consuming for all our selection lines, we 
carried it out for one of our selected populations and for a 
subset of two antibiotics. Specifically, we carried out five 
replicate measurements of activity on ampicillin for each of 
48 clones of the population selected on ampicillin (i.e., a 
total of 240 measurements). We found that the vast majority 
of the contribution to the phenotypic variance (VP≈2.19×105) 
comes from the genetic variance (VG≈2.04×105), and only a 
minor part from the environmental variance (VE≈1.5x104). 
These two variance components allow us to estimate the 
broad-sense heritability as H2=VG/VT≈0.93, meaning that 93 
 
Fig. (5). Variance, covariance, and Pearson correlation coefficients of activities on four different antibotics. The values shown in the upper 
triagonal of each matrix show the phenotypic covariance σij2of hydrolytic activities on antibiotics i and j, as listed to the left of each matrix 
row, and on the top of each matrix column. The diagonal element show the variances σi2of hydrolytic activity on antibiotic i. The values in 
the lower diagonal elements are Pearson product-moment correlation coefficients r of hydrolytic activities. Correlation coefficients in black 
type are significantly different from zero at p<0.01. All data are based on 48 TEM-1 variants, as described in the text. A) activity measure-
ments from mutagenized TEM-1 populations without selection. Values in B-E are from mutagenized TEM-1 populations selected for activity 
on B) ampicillin, C) carbenicillin, D) oxacillin, and E) penicillin G.  
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percent of the phenotypic variance is contributed by genetic 
variance. (Note that the narrow-sense heritability, an im-
portant, related concept in quantitative genetics, is meaning-
less for clonal populations like ours [70].) We also wanted to 
make sure that this high heritability is not just an artifact of 
having measured activity on the same antibiotic we selected 
for. To this end, we also measured activity on carbenicillin 
of the same ampicillin-selected clones in quintuplicate. Here, 
the environmental variance (VE=41.2) constituted an even 
smaller fraction of the phenotypic variance (VP=2007.9), 
yielding a very high heritability of H2=VG/VT≈0.98. In sum, 
these two observations show that the vast majority of the 
variance in activity reflects heritable genetic variation. If true 
for activities on all antibiotics that we considered, this means 
that the phenotypic correlations we observe (Figs 3, 4, and 5) 
largely reflect genetic correlations, which are not obscured 
by environmental variation.  
Phenotypic Hitchhiking 
 In our experiments, selection on the antibiotic ampicillin 
was most effective in increasing activity on this antibiotic. 
Given that activities covary positively for different antibiot-
ics in our data, this effectiveness may also translate into ac-
tivity increases on other antibiotics. This is indeed the case. 
More than that, in some of our selected populations, selec-
tion on one antibiotic A can lead to larger absolute increases 
in activity on antibiotic B than selection on antibiotic B it-
self. For brevity, we refer to this phenomenon as phenotypic 
hitchhiking, because activity on antibiotic B benefits indi-
rectly through an increase in activity on antibiotic A. For 
example, in the population selected on ampicillin, the mean 
activity on penicillin G was greater than in the population 
selected on penicillin G itself (p=0.0063, Mann-Whitney U-
test , Fig. 6A). The same holds for the activities on 
carbenicillin and oxacillin. They are significantly higher in 
the ampicillin-selected population than in the populations 
selected on carbenicillin (p=10-13, Mann-Whitney U-test, 
Fig. 6B) and oxacillin (p=1.6x10-7, Mann-Whitney U-test, 
Fig. 6C), respectively. The most dramatic of these differ-
ences relative to the mutagenized population occurs with 
respect to the antibiotic carbenicillin. Here, selection on 
carbenicillin increased the mean activity by more than 4.6 
fold to 64.3±21.2 relative to the mutagenized population 
(13.7±5.9, Fig. 2A), whereas selection on ampicillin in-
creased activity on carbenicillin more than 10-fold to a level 
of 138.9±47.3. This activity is somewhat higher than in the 
ancestor (123.6±6.9), although the difference to the ancestor 
in activity is not significant (p=0.77). Activities on the other 
two antibiotics were also not significantly higher (oxacillin), 
or they were slightly lower (penicillin G) than in the ances-
tor.  
 Phenotypic hitchhiking is not just restricted to the popu-
lation selected on ampicillin. For example, selection on peni-
cillin increases activity on carbenicillin more than selection 
on carbenicillin itself (p=1.3x10-7, Mann-Whitney U-test , 
Fig. 6D), even though it was not successful in raising activity 
on penicillin above the ancestor. The same holds for selec-
tion on oxacillin, which increases activity on carbenicillin to 
a greater extent than selection on carbenicillin itself (p=10-5, 
Mann-Whitney U-test, Fig. 6E). 
 Phenotypic hitchhiking is easy to explain through basic 
quantitative genetics theory [70, 71]. Quantitative genetics 
describes the change in the population mean of a multivariate 
trait 𝐳 as ∆𝐳� = 𝐆𝛃, where ∆𝐳� = �∆𝑧1̅, … ,∆𝑧?̅?� is the change 
in the means of univariate traits 1 through n after selection, 𝐆 
is a matrix of genetic covariances, and 𝛃 = (𝛽1, … ,𝛽𝑛) the 
selection gradient, a vector of partial regression coefficients 
𝛽𝑖 of fitness on trait i [71]. To see the reason why phenotypic 
hitchhiking occurs, consider the example of two hypothetical 
traits 1 and 2, where trait 1 has some genotypic value with 
mean μ1 and standard deviation σ1. Trait 2 has a greater 
mean and standard deviation, say equal to μ2=10 μ1 and 
σ2=10 σ2. If traits 1 and 2 are positively correlated, e.g., with 
a genetic correlation of 𝑟12 = 𝜎12𝜎1𝜎2 = 0.5, then the covariance 
matrix  becomes 
𝐆 = � 𝜎12 5𝜎125𝜎12 100𝜎12� 
We can now ask how trait 1 responds if selection occurs pre-
dominantly on trait 1 or on trait 2. For example, if 
, such that selection acts more strongly on trait 
1, then . Thus, the mean of 
trait 1 increases by  units. Conversely, if selection acts 
more strongly on trait 2, e.g., , the 
, and the mean of trait 1 
increases by  units. Thus, when selection acts prefer-
entially on trait 1, selection increases the mean of trait 1 by a 
smaller amount than if selection acts directly on trait 2. More 
generally, it is easy to show in this framework that phenotyp-
ic hitchhiking will occur if (i) , and if (ii) the genetic 
covariance is greater than the genetic variance  of trait 
one. Phenotypic hitchhiking is a consequence of indirect 
selection that arises in covariance matrices with these fea-
tures. One can also view it as a result of the fact that differ-
ent traits have different means and thus usually also different 
variances. Although our experiments strictly speaking do not 
reveal the structure of the genotypic covariance matrix, we 
note that the phenotypic covariance matrices of our traits 
(Fig. 5) have the required structure. For example, the covari-
ance between activity on penicillin G and ampicillin is great-
er than the variance of activity on penicillin G, but smaller 
than the variance of activity on ampicillin (Fig. 5). These are 
the conditions where activity on penicillin G can hitchhike 
on selection for ampicillin activity, exactly as we observe 
(Fig. 6A).  
DISCUSSION AND CONCLUSION 
 We analyzed to which extent mutagenesis of the TEM-1 
β-lactamase alone, or mutagenesis followed by selection on 
four different antibiotics, affects the hydrolytic activity of 
this enzyme. Mutagenesis alone significantly reduced activi-
ty on all four antibiotics. Subsequent selection partially or 
fully recovered activity on all antibiotics, but changed the 
extent to which these activities covary. Specifically, muta-
genesis alone caused highly positively correlated activities 
on the four focal antibiotics, but subsequent selection re-
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duced these correlations, and rendered the activities on sev-
eral antibiotics uncorrelated. (Not a single pair of antibiotics 
showed a significantly negative activity correlation.) The 
phenotypic covariance matrices of activity on different anti-
biotics were statistically unrelated among our five popula-
tions. We also observed several instances where selection on 
one antibiotic A can increase the activity of another antibi-
otic B to a greater extent than selection on antibiotic B itself. 
 Phenotypic and genetic covariation among traits limit 
what natural selection can achieve, because selection cannot 
shape two covarying traits independently. Typically, genetic 
studies of trait covariation compare complex morphological 
or physiological traits of multicellular organisms [20, 21, 27-
29, 44-47, 72]. To our knowledge, analyses of trait 
covariation have not yet been extensively applied to much 
simpler, molecular systems like individual proteins, although 
measurements of more than one activity in modest numbers 
of proteins are not unusual in protein engineering [18, 49, 
73-77]. The advantage that molecular systems like proteins 
have over organisms in the wild is that they can be easily 
manipulated in the laboratory through mutagenesis and dif-
ferent kinds of selection pressure.  
 One frequently asked question about macroscopic traits is 
whether patterns of trait covariation themselves are subject 
 
Fig. (6). Phenotypic hitchhiking of activities on an antibiotic. The vertical axis of each panel indicates the average (dot) and one standard 
error of the mean (whiskers) activity of 48 TEM-1 derived clones on the antibiotic whose known is shown in the inset. These clones had been 
subjected to mutagenesis followed by selection for activity on the antibiotics indicated on the x-axis. A) activity on penicillin G for lines 
selected on penicillin G and ampicillin; B) activity on carbenicillin for lines selected on carbenicillin and ampicillin; C) activity on oxacillin 
for lines selected on oxacillin and ampicillin; D) activity on carbenicillin for lines selected on carbenicillin and penicillin G; E) activity on 
carbenicillin for populations selected on carbenicillin and oxacillin. Units are mODU (min-1) (10 µl extract)-1. 
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to evolutionary change. The answer depends strongly on the 
study species, their phylogenetic diversity, and on the traits 
studied. It ranges from completely conserved to completely 
diverged covariation structure [20, 27, 28, 43-47, 72]. Perti-
nent studies often involve species that have diverged many 
generations ago, and through incompletely understood evolu-
tionary forces. In contrast, a simple study system like ours is 
ideally suited to ask how covariation patterns evolve on very 
short time scales, and under precisely controllable condi-
tions.  
 Our observations show that even a single round of selec-
tion can substantially alter phenotypic covariation patterns. 
On the one hand, mutagenesis alone resulted in a significant 
decrease in TEM-1 activity on all four antibiotics. This de-
crease was highly correlated among different antibiotics, 
with a correlation coefficient exceeding r=0.95 for each anti-
biotic pair (Fig. 5A). On the other hand, selection substan-
tially changed some of these correlations. For example, the 
correlation in activity between ampicillin and oxacillin was 
reduced from r=0.98 in the mutagenized population to r=0.87 
and r=0.69 in the populations selected on penicillin G and on 
ampicillin, respectively. The correlation became indistin-
guishable from zero in populations selected on carbenicillin 
and oxacillin (Fig. 5). The extent of this reduction does not 
only depend on the selection pressure applied, but also on the 
antibiotic pair. For example, while activity correlations be-
tween ampicillin and penicillin G were high (r>0.88) in pop-
ulations selected on ampicillin and oxacillin (and in all other 
populations as well), those between ampicillin and 
carbenicillin became insignificant after selection on these 
two antibiotics. Common principal component analysis [60, 
64] showed that the covariance matrices of activities on the 
four different antibiotics have little similarity. These obser-
vations show that selection can rapidly change trait 
covariances and correlation. We caution that we only esti-
mated the phenotypic component of covariation among 
traits, but not its genetic component. Estimation of the latter 
is much more laborious, even though phenotypic covariation 
is often a good reflection of genetic covariation [27]. We did, 
however, demonstrate a very high broad-sense heritability of 
activity on carbenicillin and ampicillin (H2>0.92), showing 
that the vast majority of the variance in these activities is 
genetic variance. If the same holds for the other activities we 
analyzed, then the patterns of change in phenotypic covari-
ance we observe reflect changes in genetic covariance.  
 One might argue that a reduction in genetic variation 
caused by selection may be partly responsible for the smaller 
phenotypic correlations we see between many traits after 
selection. Specifically, selection might reduce the genetic 
variance in a trait caused by mutagenesis, such that environ-
mental variance becomes relatively more important. This 
environmental variance might obscure genetic correlations 
among our traits, leading to smaller phenotypic correlations. 
We note that our very high estimates of heritability after se-
lection argue against this possibility.  
 In contrast to more complex traits, the simple traits we 
study may allow at least some insight into the proximate 
reason between trait covariation. Fig. (7), for example, 
shows the chemical structures of the four antibiotics used in 
this study, where parts of the molecules in common between 
all four antibiotics are shaded in gray. The Figure illustrates 
that ampicillin is highly similar to penicillin G – the two 
differ in a single amino group – but quite different from 
oxacillin. The high similarity between ampicillin and penicil-
lin G may explain why activity correlations between them 
are uniformly high in all five populations. In contrast, the 
correlation between activity on ampicillin and oxacillin is 
much more variable among the five enzyme populations we 
studied. Specifically, depending on the selection pressure 
applied, these correlations can assume values different from 
one another, where one may be significantly different from 
zero, whereas the other is not. These differences may reflect 
the greater chemical differences between these antibiotics. 
However, chemical similarity or dissimilarity may not ex-
plain all of the differences in covariation patterns we ob-
serve. For example, carbenicillin is also quite similar to am-
picillin, and differs from it only in a carboxyl group. None-
theless, selection is much less effective in increasing activity 
on carbenicillin than on ampicillin (Fig. 2A and Fig. 2D). 
Also, the covariation between activity on ampicillin and 
carbenicillin is no less variable than the covariation between 
the much more diverse oxacillin and ampicillin (Fig. 5). Ul-
timately, to understand patterns like this we would need to 
know how β-lactamase interacts with different antibiotics on 
an atomic scale, and how different β-lactamase mutants dif-
fer in this interaction, as well as in other properties, such as 
their thermodynamic stability. For other proteins, a combina-
tion of experimental and computational work is beginning to 
facilitate understanding of how biophysical and chemical 
properties like these can affect the molecular evolution of 
proteins [78-85]. But even though β-lactamases are extreme-
ly well-studied biochemically and evolutionarily, their inter-
actions with antibiotics are still insufficiently understood. 
Recent progress is being made in this area [86-88]. If it con-
tinues, we will be able to link the biophysics and biochemis-
try of these enzymes to the population-wide patterns we ob-
served.  
 Trade-offs between traits are not only important to evolu-
tionary biologists [37-42], but also to protein engineers, as 
they can severely limit possibilities to improve any one trait. 
Available evidence for such trade-offs in proteins typically 
involve few (as little as two) mutant proteins and their activi-
ty on two different substrates [18, 73-77]. If one mutant has a 
high activity on substrate A and a low activity on substrate 
B, whereas another mutant shows the opposite relationship, a 
trade-off may exist. However, to infer trade-offs based on 
few variants has serious limitations, as the example of  
Fig. (8) illustrates. The figure shows the activities on penicil-
lin G and oxacillin of 48 clones selected on oxacillin. The 
vertical and horizontal solid lines show the activities of the 
TEM-1 ancestor. There are several clones with higher than 
ancestral activity on oxacillin, and lower than ancestral activ-
ity on penicillin G (upper left quadrant), or vice versa (lower 
right quadrant). Comparison of individual such clones to the 
wild-type could be construed as evidence for a trade-off. 
However, the overall association between the activities is not 
significantly different from zero (r=-0.07), and no evidence 
of a trade-off exist. This simple example shows that unless a 
number of variants high enough for statistical analysis is 
examined, solid evidence for a trade-off is hard to come by. 
In our five study population, no two antibiotic activities 
show a trade-off. The reason may lie in the chemical similar-
ity of the antibiotics we studied, as more distantly related 
antibiotics, such as cefotaxime or ceftazidime with bulkier 
side chains may display such trade-offs [74].  
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 Our observation of phenotypic hitchhiking implies that to 
increase activity on a substrate A, it may not always be best 
to select for activity on A itself, but instead on a related sub-
strate B where activity covaries positively with activity on A. 
We observed phenotypic hitchhiking for selection on ampi-
cillin, where selection increased activity on P, O, or C to a 
greater extent than selection on P, O, or C itself (Fig. 6A-
6C). We also observed it, to a lesser extent, for selection on 
penicillin G and oxacillin (Fig. 6D and E). Basic quantitative 
genetic theory implies that phenotypic hitchhiking occurs 
when the genotypic variances (𝜎12,𝜎22) and covariance (𝜎12) 
of activity on substrate 1 and 2 follow the order relation 
𝜎1
2 < 𝜎12<𝜎22. Phenotypic hitchhiking can thus be viewed as 
a simple consequence of the fact that different, positively 
covarying traits, have different variances. For some applica-
tions, such as to compare the relative changes in traits that 
selection can achieve, it may be best to rescale and standard-
ize trait means or variances [29, 89]. However, wherever 
absolute changes in a trait matter most, for example in many 
biotechnological applications, such rescaling may not be 
appropriate.  
 The extent of phenotypic hitchhiking will depend on the 
extent to which the variances and covariances of two traits 
differ. For example, in our experiments phenotypic hitchhik-
ing was most effective involving selection on ampicillin 
(Fig. 6A-6C), because ampicillin activity shows a much 
greater variance than other activities, as well as a high posi-
tive covariance with the other three traits (Fig. 5). (Although 
the (co)variances we observe are phenotypic and not geno-
typic co-variances, the fact that our analysis is based on 
clonal populations, and our partial analysis of heritability 
suggest that the two kinds of (co)variances will be similar.) 
Phenotypic hitchhiking may have practical applications. For 
example, if one desires to improve the activity of a promis-
cuous enzyme on some substrate B, and if directed evolution 
is known to be able to improve activity on a closely related 
substrate A, then selection on A may be an effective strategy 
to increase activity on B.  
 We view our study as a first step towards applying anal-
yses of trait covariation to molecular systems, and are well 
aware that it leaves many open questions. How dramatically 
can selection alter trade covariation over longer time scales, 
that is, after multiple rounds of selection? Will negative 
trade-offs between activities arise where none existed be-
fore? How well can selection alleviate such trade-offs? How 
dissimilar do the substrates of an enzyme need to be before 
negative trade-offs arise? Simple molecular systems may 
help answer questions about trait covariation that speak to 
long-standing questions in evolutionary biology which are 
difficult to address in more complex systems. 
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Fig. (7). Chemical structure of the four antibiotics used in this study. The shaded area includes groups shared by all four antibiotics. 
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